LondonCurrent immunotherapy ignores a sex-specific immune brake.
GABA amplifies immune-suppressing cells in female glioblastoma tumors only — a sex-specific effect current protocols miss, researchers found.
If the pathway holds clinically, glioblastoma treatment may need sex-differentiated dosing.
Sources: Nature